Kamada KMDA 深 沪
已收盘 12-19 16:00:00 美东时间
7.275
+0.055
+0.76%
华盛通- 最 高7.4471
- 今 开7.15
- 成交量 6.67万股
- 最 低 6.631
- 昨 收 7.22
- 总市值 3.26亿
- 52周最高 9.15
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 5.54
- 委 比 52.38%
- 总股本 4480.05万
- 历史最高 17.95
- 量 比 1.01
- 振 幅 11.30%
- 历史最低 1.10
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook
Kamada ends its Phase 3 inhaled AAT trial after a futility analysis but maintains 2025 guidance and forecasts double-digit growth in 2026.
12-09 00:05
Kamada Reiterates its 2025 Revenue Guidance of $178M-$182M Vs. Consensus Of $180.66M, And Adjusted EBITDA of $40M-$44M
Kamada Projects Double-Digit Growth in Revenues and Profitability in 2026; Detailed Guidance to be Provided in January 2026
12-08 20:08
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
Kamada Ltd. announced it continues operations and manufacturing at its Israeli facility amid evolving Middle East circumstances, ensuring uninterrupted global product availability. Despite potential temporary shipment delays due to Israeli airspace closure, distribution centers and partners have sufficient inventory to meet client demands.
06-17 11:00
Tilray Brands盘中异动 快速下挫5.00%
北京时间2025年02月11日02时40分，Tilray Brands, Inc.（TLRY.us）股票出现异动，股价快速下挫5.00%。截至发稿，该股报0.950美元/股，成交量5499.75万股，换手率5.89%，振幅5.99%。 最近的财报数据显示，该股实现营业收入2.11亿美元，净利润-85.34百万美元，每股收益-0.10美元，毛利38.29百万美元，市盈率-3.17倍。 机构评级方面，在所有15家参与评级的机构中，27%的券商给予买入建议，73%的券商给予持有建议，无券商给予卖出建议。 Tilray Brands, Inc.股票所在的制药行业中，整体跌幅为0.76%。其相关个股中，...
02-11 02:40
Kamada Expands US Plasma Operations with Houston Center, Plans FDA Submission
Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)))), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today
2024-09-23 19:19
HC Wainwright & Co. Reiterates Buy on Kamada, Maintains $11 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Kamada (NASDAQ:KMDA) with a Buy and maintains $11 price target.
2024-08-16 00:42
